Piperacillin Sodium, Tazobactam Sodium

• Nebulized Amikacine for Ventilator associated gram negative Pneumonia in ECMO veno-arterial patients: A randomized Pilot Study (NAVAP-ECMO) Pending
  2023-509722-22-00 Phase II 1 country Assistance Publique Hopitaux De Paris
• Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending
  2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
• BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending
  2024-516849-39-01 Phase III 1 country Assistance Publique Hopitaux De Paris
• LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending
  2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
• Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) Recruiting
  2023-509703-33-00 Phase IV 2 countries Rigshospitalet
• TRI-AB trial Recruiting
  2024-520251-24-00 Phase IV 1 country Odense University Hospital
• Benefits of early discontinuation of antibiotic therapy versus standard management in elderly patients hospitalized for viral infection: a m… Recruiting
  2024-515695-13-00 Phase III/IV 1 country Centre Hospitalier Universitaire Amiens Picardie
• Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting
  2023-503447-33-00 Phase II 2 countries Uppsala Universitet
• A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose AntimicRobials vs conventional dos… Recruiting
  2024-514730-21-00 Phase III 2 countries Universitair Ziekenhuis Gent
• Aminoglycosides in early sepsis Recruiting
  2024-519797-39-00 Phase IV 1 country Akershus University Hospital
• Intravenous Fosfomycin in hospitalized patients with complicated urinary tract infections due to Third-generation cephalosporinresistant Ent… Recruiting
  2024-516591-15-00 Phase IV 1 country Azienda Ospedaliero Universitaria Di Modena
• Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting
  2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Piperacillin-tazobactam and temocillin as carbapenem-alternatives for the treatment of severe infections due to extended-spectrum beta-lacta… Recruiting
  2024-511866-36-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Use of MULTIplex PCR, procalcitonin and the appearance of sputum to reduce the duration of antibiotic therapy during severe COPD EXAcerbatio… Recruiting
  2024-511896-13-00 Phase III/IV 1 country Assistance Publique Hopitaux De Paris
• A2B-trial Antibioprophylaxis for excision-graft surgery in burn patient : a multicenter randomized double-bling study Recruiting
  2024-514349-13-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ended
  2023-508456-18-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended
  2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht

Showing 1–17 of 17 trials